CEO Resignation Novo Nordisk - Search News

Order byBest matchMost fresh

News

Novo Nordisk ousts CEO

Novo Nordisk Places Bet on CEO Shake-Up to Reclaim Edge in Weight Loss Drug Race

As its obesity medication Wegovy loses a sizable portion of the market to Eli Lilly and Company (NYSE:LLY)’s competing medicine, Zepbound, the Danish pharmaceutical behemoth Novo Nordisk A/S (NYSE:NVO) abruptly announced the resignation of veteran CEO Lars Fruergaard Jørgensenm last week.

Continue reading

· 1h · on MSN

· 4d · on MSN

Novo Nordisk ousts CEO after falling behind in weight loss market

· 4d · on MSN

Novo Nordisk's CEO is out after the Ozempic maker's stock dropped 50% in a year

Barchart on MSN4d

Is Novo Nordisk Stock a Buy, Sell, or Hold as CEO Lars Fruergaard Jørgensen Resigns?

Novo Nordisk (NVO) is in focus on Friday after its long-time chief executive Lars Fruergaard Jørgensen announced his ...

4d

Novo Nordisk CEO Lars Fruergaard Jorgensen to resign as Ozempic faces stiff competition

The CEO of Danish pharmaceutical giant Novo Nordisk, known for its blockbuster weight-loss drug Ozempic, will step down, the ...

4don MSN

CEO of Novo Nordisk, maker of weight loss drug Wegovy, to step down in wake of share price drop

Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results